| scholarly article | Q13442814 |
| P50 | author | Sundeep Khosla | Q42164143 |
| B. Lawrence Riggs | Q99569923 | ||
| W. Michael O'Fallon | Q102207830 | ||
| L. Joseph Melton | Q112619624 | ||
| Elizabeth J Atkinson | Q112620107 | ||
| P2093 | author name string | Klee GG | |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2266-2274 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. | |
| P478 | volume | 83 |
| Q34300668 | 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. |
| Q34701112 | A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men |
| Q36827273 | A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog |
| Q37020896 | Abdominal aortic calcification, BMD, and bone microstructure: a population-based study. |
| Q47555054 | Aberrant tryptophan transport in cultured fibroblast from patients with Male Idiopathic Osteoporosis: An in vitro study |
| Q24811304 | Abnormal bone composition in female juvenile American alligators from a pesticide-polluted lake (Lake Apopka, Florida) |
| Q37027277 | Affective Disorders, Bone Metabolism, and Osteoporosis |
| Q84137036 | Age-related changes in biochemical markers of bone turnover and gonadotropin levels and their relationship among Chinese adult women |
| Q44752083 | Age-related changes in sex steroid levels influence bone mineral density in healthy Indian men. |
| Q30625276 | Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: cross-sectional data from a healthy male cohort |
| Q37051610 | Aging, lifestyle factors, hormones and bone health in Singaporean men. |
| Q44589075 | Alendronate treatment of established primary osteoporosis in men: 3-year results of a prospective, comparative, two-arm study |
| Q37130282 | Alterations of T cell activation signalling and cytokine production by postmenopausal estrogen levels |
| Q51358380 | An altered hormonal profile and elevated rate of bone loss are associated with low bone mass in professional horse-racing jockeys. |
| Q31142476 | An integrative review on current evidence of testosterone replacement therapy for the andropause |
| Q55512155 | Analysis of correlation between estradiol and fracture of femur neck. |
| Q34617845 | Androgen deprivation therapy for prostate cancer: new concepts and concerns |
| Q24551170 | Androgen replacement therapy in the aging male |
| Q79811504 | Androgens and bone |
| Q34395346 | Androgens and estrogens in skeletal sexual dimorphism. |
| Q34511442 | Andropause: clinical implications of the decline in serum testosterone levels with aging in men. |
| Q41078194 | Are bone turnover markers associated with volumetric bone density, size, and strength in older men and women? The AGES-Reykjavik study |
| Q35101538 | Aromatase activity and bone loss in men. |
| Q35128738 | Aromatase inhibitors in men: effects and therapeutic options |
| Q45097773 | Assessment of the role of 17beta-oestradiol in bone metabolism in men: does the assay technique matter? The MINOS study. |
| Q51249802 | Association Between Bone Mineral Density and Pancreatic β-Cell Function in Elderly Men and Postmenopausal Women. |
| Q35218202 | Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study |
| Q34874904 | Association between depressive symptoms and bone stiffness index in young adults: the Kangwha study |
| Q37520069 | Association between estrogen receptor α gene (ESR1) PvuII (C/T) and XbaI (A/G) polymorphisms and hip fracture risk: evidence from a meta-analysis |
| Q49573138 | Association of BAP with urinary albumin excretion in postmenopausal, but not premenopausal, non-CKD Japanese women |
| Q36158023 | Association of SLC2A9 genotype with phenotypic variability of serum urate in pre-menopausal women |
| Q36986530 | Association of sarcopenia and physical activity with femur bone mineral density in elderly women |
| Q37673461 | Associations between Body Composition, Hormonal and Lifestyle Factors, Bone Turnover, and BMD. |
| Q34045842 | Background for studies on the treatment of male osteoporosis: state of the art. |
| Q39963703 | Bioavailable Testosterone Linearly Declines Over A Wide Age Spectrum in Men and Women From The Baltimore Longitudinal Study of Aging |
| Q36848797 | Biochemical assessment of bone turnover and bone fragility in men. |
| Q34239361 | Biochemical markers of bone turnover: part I: biochemistry and variability |
| Q35063675 | Bisphosphonates to prevent osteoporosis in men receiving androgen deprivation therapy for prostate cancer |
| Q55274146 | Body Composition and Bone Mineral Density in Patients With Heart Failure. |
| Q34806465 | Body mass index and colon cancer risk in Chinese people: menopause as an effect modifier |
| Q38408283 | Bone ALP and OC reference standards in adult baboons (Papio hamadryas) by sex and age. |
| Q90405151 | Bone Safety During the First Ten Years of Gender-Affirming Hormonal Treatment in Transwomen and Transmen |
| Q34497563 | Bone density in chronic schizophrenia with long-term antipsychotic treatment: preliminary study |
| Q53231997 | Bone density in women with prolactinoma treated with dopamine agonists. |
| Q57823069 | Bone health and evaluation of bone mineral density in patients with premature ovarian insufficiency |
| Q33591342 | Bone metabolism in obesity and weight loss |
| Q33716426 | Bone microstructure in men assessed by HR-pQCT: Associations with risk factors and differences between men with normal, low, and osteoporosis-range areal BMD. |
| Q46976554 | Bone mineral density and its determinants in diabetes: the Fremantle Diabetes Study |
| Q81402731 | Bone mineral density and osteoporosis among a predominantly Caucasian elderly population in the city of São Paulo, Brazil |
| Q73694194 | Bone mineral density and serum levels of aminoterminal propeptides and cross-linked N-telopeptides of type I collagen in elderly men |
| Q51758552 | Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. |
| Q34130913 | Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement |
| Q43890518 | Bone phenotype of the aromatase deficient mouse |
| Q34241748 | Bone turnover across the menopause transition : The role of gonadal inhibins. |
| Q33275032 | Bone turnover in elderly men: relationships to change in bone mineral density |
| Q34544147 | Bone turnover predicts change in volumetric bone density and bone geometry at the radius in men |
| Q37039594 | Bone-targeted agents: preventing skeletal complications in prostate cancer |
| Q33378962 | Bones and Crohn's: estradiol deficiency in men with Crohn's disease is not associated with reduced bone mineral density |
| Q37681749 | Breast cancer: trends in international incidence in men and women |
| Q44363695 | Can DHEA be used to prevent bone loss and osteoporosis? |
| Q84453315 | Capacity of endogenous sex steroids to predict bone loss in Japanese men: 10-year follow-up of the Taiji Cohort Study |
| Q36736507 | Challenges to the measurement of estradiol: an endocrine society position statement |
| Q51429061 | Circulating adiponectin represents a biomarker of the association between adiposity and bone mineral density. |
| Q45215925 | Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males |
| Q43937308 | Clinical and biochemical determinants of bone metabolism and bone mass in adolescent female patients with anorexia nervosa |
| Q24814334 | Comparison of plasma endothelin levels between osteoporotic, osteopenic and normal subjects |
| Q37085340 | Comparison of sex steroid measurements in men by immunoassay versus mass spectroscopy and relationships with cortical and trabecular volumetric bone mineral density |
| Q37055781 | Correlates of trabecular and cortical volumetric bone mineral density at the femoral neck and lumbar spine: the osteoporotic fractures in men study (MrOS). |
| Q36732699 | Correlations between serum testosterone, estradiol, and sex hormone-binding globulin and bone mineral density in a diverse sample of men |
| Q44297420 | Cross-sectional study of bone turnover during bicalutamide monotherapy for prostate cancer |
| Q38648384 | Cross-sex testosterone therapy in ovariectomized mice: addition of low-dose estrogen preserves bone architecture. |
| Q43254331 | Daidzein administration positively affects thyroid C cells and bone structure in orchidectomized middle-aged rats |
| Q46485425 | Dehydroepiandrosterone sulfate and bone resorption rates as reflected by serum levels of C-terminal telopeptide of type I collagen: a study in healthy men. |
| Q36925842 | Depression and osteoporosis: epidemiology and potential mediating pathways |
| Q50532037 | Depression and risk of fracture and bone loss: an updated meta-analysis of prospective studies. |
| Q40747297 | Determinants of bone density in healthy older men with low testosterone levels |
| Q43603123 | Determinants of bone mineral density in Chinese men. |
| Q35148570 | Determinants of forearm strength in postmenopausal women. |
| Q46794177 | Differences in sensitivity to cold in Japanese men and postmenopausal women aged > or =50 years |
| Q36727188 | Differences in trabecular bone of leptin-deficient ob/ob mice in response to biomechanical loading |
| Q28295303 | Disorders of Bone Remodeling |
| Q57224267 | Dissimilarity of femur aging in men and women from a Nationwide Survey in Korea (KNHANES IV) |
| Q33882678 | Does the cortical bone resorption rate change due to 90Sr-radiation exposure? Analysis of data from Techa Riverside residents |
| Q46877450 | Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism |
| Q34136135 | Effect of in utero exposure to diethylstilbestrol on lumbar and femoral bone, articular cartilage, and the intervertebral disc in male and female adult mice progeny with and without swimming exercise |
| Q40357185 | Effect of sex steroids on bone formation in an orthopedically expanded suture in rats : An immunohistochemical and computed tomography study |
| Q55344691 | Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trial. |
| Q35786468 | Effects of Age and Estrogen on Skeletal Gene Expression in Humans as Assessed by RNA Sequencing |
| Q26739664 | Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences |
| Q90656508 | Effects of Estrogen Replacement on Bone Geometry and Microarchitecture in Adolescent and Young Adult Oligoamenorrheic Athletes: A Randomized Trial |
| Q41010298 | Effects of Testosterone and Estradiol Deficiency on Vasomotor Symptoms in Hypogonadal Men. |
| Q37482736 | Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. |
| Q34578101 | Effects of the methanol extract of Basella alba L (Basellaceae) on steroid production in Leydig cells |
| Q33943952 | Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels |
| Q33786842 | Effects on lipoprotein particles of long-term dehydroepiandrosterone in elderly men and women and testosterone in elderly men. |
| Q36338679 | Endocrine regulation of bone turnover in men. |
| Q34777308 | Endocrinology of the aging male |
| Q44776225 | Endogenous estradiol and the risk of incident fracture in postmenopausal women: the OPUS study. |
| Q46862560 | Endogenous sex steroids and bone mineral density in healthy Greek postmenopausal women |
| Q47334216 | Endogenous sex steroids, weight change and rates of hip bone loss in older men: the MrOS study. |
| Q36565216 | Epidemiology and pathophysiology of osteoporosis in men. |
| Q82723971 | Epidemiology of osteoporosis |
| Q83770424 | Epidemiology of osteoporosis |
| Q36909998 | Estrogen and bone: insights from estrogen-resistant, aromatase-deficient, and normal men. |
| Q35835789 | Estrogen receptor α (ESR1) IVS1-397T>C polymorphism lowers risk of fracture |
| Q34543980 | Estrogens and Androgens in Skeletal Physiology and Pathophysiology |
| Q37520591 | Estrogens as regulators of bone health in men. |
| Q40577247 | Exploratory analysis of the potential relationship between urinary molybdenum and bone mineral density among adult men and women from NHANES 2007-2010. |
| Q35028357 | Follicle-stimulating hormone and bioavailable estradiol are less important than weight and race in determining bone density in younger postmenopausal women |
| Q35635694 | Follicle-stimulating hormone is independently associated with lean mass but not BMD in younger postmenopausal women |
| Q46507213 | Free testosterone levels and implications on clinical outcomes in elderly men. |
| Q28385120 | From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis |
| Q80297684 | Fundamental aspects of hypogonadism in the aging male |
| Q92111740 | Gender-Affirming Hormone Treatment Decreases Bone Turnover in Transwomen and Older Transmen |
| Q36208502 | Genetic variant of Interleukin-18 gene is associated with the Frailty Index in the English Longitudinal Study of Ageing |
| Q37189990 | Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men. |
| Q34680024 | Genistein supplementation increases bone turnover but does not prevent alcohol-induced bone loss in male mice. |
| Q90354923 | Glucocorticoid-induced osteoporosis: from clinical trials to clinical practice |
| Q36618559 | Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. |
| Q34081897 | Gonadal steroids and body composition, strength, and sexual function in men |
| Q43843500 | Growth hormone and sex steroid effects on bone metabolism and bone mineral density in healthy aged women and men. |
| Q40415636 | Higher bone mineral density in Caucasian, hirsute patients of reproductive age. Positive correlation of testosterone levels with bone mineral density in hirsutism |
| Q37072420 | Higher muscle protein synthesis in women than men across the lifespan, and failure of androgen administration to amend age-related decrements. |
| Q34758514 | Higher serum free testosterone concentration in older women is associated with greater bone mineral density, lean body mass, and total fat mass: the cardiovascular health study |
| Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
| Q89207431 | Hypogonadotropic Hypogonadism in Men With Diabesity |
| Q44818658 | IGF-I and testosterone levels as predictors of bone mineral density in healthy, community-dwelling men. |
| Q34249855 | Idiopathic osteoporosis: an evolutionary dys-adaptation? |
| Q37376419 | Impact + resistance training improves bone health and body composition in prematurely menopausal breast cancer survivors: a randomized controlled trial |
| Q92558008 | Increase in Osteocalcin Following Testosterone Therapy in Men With Type 2 Diabetes and Subnormal Free Testosterone |
| Q58781450 | Increased Bone Mineral Density after Abstinence in Male Patients with Alcohol Dependence |
| Q33739241 | Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men. |
| Q46381374 | Inhibin and the regulation of bone mass |
| Q36890245 | Integrated expression analysis of muscle hypertrophy identifies Asb2 as a negative regulator of muscle mass |
| Q30307314 | Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2. |
| Q43737816 | Inverse association between bone turnover rate and bone mineral density in community-dwelling men >70 years of age: no major role of sex steroid status |
| Q36984010 | Is there any association between leptin levels and bone mineral density in haemophiliac men? |
| Q35093569 | Japanese medaka: a non-mammalian vertebrate model for studying sex and age-related bone metabolism in vivo. |
| Q30452982 | Kinase-mediated regulation of common transcription factors accounts for the bone-protective effects of sex steroids |
| Q36271670 | Lasofoxifene (CP-336,156), a novel selective estrogen receptor modulator, in preclinical studies |
| Q26745567 | Lessons from the Bone Chapter of the Malaysian Aging Men Study |
| Q33920309 | Loading-related regulation of gene expression in bone in the contexts of estrogen deficiency, lack of estrogen receptor alpha and disuse |
| Q44241718 | Low body mass index and declining sex steroids explain most age-related bone loss in Brazilian men. |
| Q37273799 | Lower Limb Metaphyseal Bone Is Lost in Men with Coeliac Disease and Does Not Relate to Parathyroid Status |
| Q26752674 | Major osteoporotic fragility fractures: Risk factor updates and societal impact |
| Q33687994 | Male Skeletal Health and Osteoporosis |
| Q35692900 | Male hypogonadism in the primary care clinic |
| Q36700839 | Male osteoporosis. |
| Q36568540 | Male osteoporosis: A review |
| Q36203210 | Male osteoporosis: epidemiology and pathophysiology |
| Q36255238 | Male osteoporosis: new trends in diagnosis and therapy |
| Q44466090 | Management of treatment-related osteoporosis in men with prostate cancer |
| Q37823835 | Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards. |
| Q90482437 | Mechanisms of Sex Disparities in Cardiovascular Function and Remodeling |
| Q37425935 | Medaka fish exhibits longevity gender gap, a natural drop in estrogen and telomere shortening during aging: a unique model for studying sex-dependent longevity |
| Q44961176 | Men with osteoporosis: are they being treated fairly? |
| Q35121399 | Men, bone and estrogen: unresolved issues. |
| Q33781733 | Menstrual irregularity and bone mass in premenopausal women: cross-sectional associations with testosterone and SHBG. |
| Q38303979 | Muscle wasting in disease: molecular mechanisms and promising therapies |
| Q35853649 | Myostatin as a mediator of sarcopenia versus homeostatic regulator of muscle mass: insights using a new mass spectrometry-based assay |
| Q36207061 | Oestradiol levels and superoxide dismutase activity in age-related cataract: a case-control study. |
| Q34592284 | Oestrogen, bones and men: when testosterone just isn't enough. |
| Q34023510 | Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer |
| Q37146402 | Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial. |
| Q38121599 | Osteogenic effects of resveratrol in vitro: potential for the prevention and treatment of osteoporosis |
| Q37198504 | Osteoporosis and cancer |
| Q34856701 | Osteoporosis during androgen deprivation therapy for prostate cancer |
| Q57244901 | Osteoporosis in Men |
| Q34993317 | Osteoporosis in elderly: prevention and treatment |
| Q56110001 | Osteoporosis in men |
| Q77322332 | Osteoporosis in men |
| Q43687778 | Osteoporosis in men: a potential role for the sex hormone binding globulin |
| Q35680543 | Osteoporosis in men: epidemiology, diagnosis, prevention, and treatment |
| Q46446900 | Osteoporosis in men: epidemiology, physiopathology, diagnosis, prevention and treatment |
| Q36056965 | Osteoporosis in men: insights for the clinician |
| Q37192997 | Osteoporosis in men: its pathophysiology and the role of teriparatide in its treatment. |
| Q74156843 | Osteoporosis in older men |
| Q37259537 | Osteoporosis risk prediction for bone mineral density assessment of postmenopausal women using machine learning |
| Q55496540 | Pathogenesis of Osteoporosis. |
| Q37305810 | Pathogenesis of age-related bone loss in humans |
| Q44543671 | Pathogenesis of bone loss in heart transplant candidates and recipients |
| Q34435647 | Pathogenesis of postmenopausal osteoporosis |
| Q38197194 | Physical activity and bone health |
| Q33980978 | Physiology of bone loss |
| Q36772834 | Polymorphisms in the CYP19 gene that influence bone mineral density |
| Q35843952 | Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis |
| Q42982601 | Poor response to pegylated interferon and ribavirin in older women infected with hepatitis C virus of genotype 1b in high viral loads |
| Q37994106 | Prevalence and seasonal variation of hypovitaminosis D and its relationship to bone metabolism in healthy Hungarian men over 50 years of age: the HunMen Study. |
| Q26778415 | Prostate cancer stem cells: the role of androgen and estrogen receptors |
| Q35074530 | Quantification of the relative contribution of estrogen to bone mineral density in men and women |
| Q35380592 | RANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis |
| Q37085390 | Recent topics related to testosterone deficiency syndrome in Japan |
| Q38657323 | Regulation of Bone Metabolism by Sex Steroids |
| Q37189981 | Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength |
| Q35230055 | Relation of age, gender, and bone mass to circulating sclerostin levels in women and men. |
| Q37026119 | Relationship Between Urinary Cross-Linked N-Telopeptide of Type-I Collagen and Heel Stiffness Index Measured by Quantitative Ultrasound in Middle-Aged and Elderly Men |
| Q44445621 | Relationship between PTH, sex steroid and bone turnover marker measurements and bone density in recently postmenopausal women. |
| Q49711953 | Relationship between bone turnover markers and the heel stiffness index measured by quantitative ultrasound in middle-aged and elderly Japanese men. |
| Q64983831 | Relationship between sex hormone levels, bone mineral density and bone turnover markers in healthy moroccan men: a cross-sectional study. |
| Q36831880 | Relationship of adiposity to bone volumetric density and microstructure in men and women across the adult lifespan |
| Q36403582 | Relationship of sex steroid hormones with body size and with body composition measured by dual-energy X-ray absorptiometry in US men. |
| Q36387995 | Relationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men. |
| Q34315799 | Relationship of volumetric bone density and structural parameters at different skeletal sites to sex steroid levels in women |
| Q37272054 | Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men |
| Q38099508 | Risks and benefits of testosterone therapy in older men. |
| Q34280148 | Role of estrogen on bone in the human male: insights from the natural models of congenital estrogen deficiency. |
| Q35765591 | Role of hormonal changes in the pathogenesis of osteoporosis in men. |
| Q44507232 | Role of parathyroid hormone in mediating age-related changes in bone resorption in men. |
| Q44965046 | Role of sex steroids in the regulation of bone morphology in men. The MINOS study. |
| Q34632171 | SERI Surgical Scaffold as an Adjunct for Circumferential Abdominoplasty and Lower Body Lift |
| Q36241734 | Sarcopenia of aging and its metabolic impact |
| Q35532443 | Sarcopenia: An emphasis on occlusion training and dietary protein. |
| Q80297345 | Selective estrogen receptor modulators to prevent treatment-related osteoporosis |
| Q33321301 | Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women |
| Q37409638 | Serum concentrations of estradiol and free T4 are inversely correlated with sperm DNA damage in men from an infertility clinic |
| Q36089176 | Serum sex steroid hormones and frailty in older American men of the Third National Health and Nutrition Examination Survey (NHANES III) |
| Q51557446 | Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome. |
| Q36157134 | Serum testosterone, sex hormone-binding globulin and total calcium levels predict the calcaneal speed of sound in men. |
| Q35685183 | Sex Differences in Antiretroviral Therapy Initiation in Pediatric HIV Infection |
| Q37605194 | Sex and the single nucleotide polymorphism: exploring the genetic causes of skeletal sex differences. |
| Q35063350 | Sex differences in forearm vasoconstrictor response to voluntary apnea. |
| Q28731543 | Sex differences in the association between serum levels of testosterone and frailty in an elderly population: the Toledo Study for Healthy Aging |
| Q40227719 | Sex hormone levels as determinants of bone mineral density and osteoporosis in Vietnamese women and men. |
| Q36644735 | Sex hormones in Malay and Chinese men in Malaysia: are there age and race differences? |
| Q37130045 | Sex hormones, their receptors and bone health |
| Q34113083 | Sex steroid hormones in older men: longitudinal associations with 4.5-year change in hip bone mineral density--the osteoporotic fractures in men study |
| Q36995890 | Sex steroids and bone health in men. |
| Q57606310 | Sex steroids and bone health in older Chinese men |
| Q36369307 | Sex steroids and bone health status in men. |
| Q37223066 | Sex-specific genetic architecture of human disease |
| Q36820895 | Skeletal muscle mass is associated with bone geometry and microstructure and serum insulin-like growth factor binding protein-2 levels in adult women and men. |
| Q24647679 | Testosterone for the aging male; current evidence and recommended practice |
| Q34995426 | Testosterone increases bone mineral density in female-to-male transsexuals: a case series of 15 subjects |
| Q33745729 | Testosterone replacement therapy in older adult men. |
| Q33961723 | The ESR1 (6q25) locus is associated with calcaneal ultrasound parameters and radial volumetric bone mineral density in European men. |
| Q36539171 | The discovery of how gender influences age immunological mechanisms in health and disease, and the identification of ageing gender-specific biomarkers, could lead to specifically tailored treatment and ultimately improve therapeutic success rates |
| Q46756254 | The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL. |
| Q35198516 | The epidemiology of osteoporosis and fractures in geriatric medicine |
| Q35109134 | The importance of oestrogens in males. |
| Q35611123 | The influence of genetic variability and proinflammatory status on the development of bone disease in patients with Gaucher disease |
| Q36625952 | The need for increasing awareness of osteoporosis in men. |
| Q37017423 | The osteoporotic male: overlooked and undermanaged? |
| Q34995316 | The pathogenesis of osteoporosis in older women and men: a review |
| Q38074897 | The pathogenesis, treatment and prevention of osteoporosis in men. |
| Q73920240 | The relation between bone density, free androgen index, and estradiol in men 60 to 70 years old |
| Q31159652 | The relation of the XbaI and PvuII polymorphisms of the estrogen receptor gene and the CAG repeat polymorphism of the androgen receptor gene to peak bone mass and bone turnover rate among young healthy men. |
| Q46629440 | The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. |
| Q40828040 | The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian Bone Club. |
| Q46145361 | The role of estrogen receptor-alpha gene TA polymorphism and aromatase gene TTTA polymorphism on peak bone mass attainment in males: is there an additive negative effect of certain allele combinations? |
| Q35108989 | The role of estrogens in men and androgens in women. |
| Q36324969 | The role of the immune system in the pathophysiology of osteoporosis |
| Q30743833 | The structural basis of bone fragility in men. |
| Q35229894 | The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed? |
| Q36395060 | Therapy Insight: osteoporosis during hormone therapy for prostate cancer |
| Q34619585 | Three-dimensional structural analysis of the proximal femur in an age-stratified sample of women. |
| Q34960850 | Toremifene increases bone mineral density in men receiving androgen deprivation therapy for prostate cancer: interim analysis of a multicenter phase 3 clinical study |
| Q36564415 | Towards a diagnostic and therapeutic consensus in male osteoporosis |
| Q37478020 | Transdermal testosterone replacement therapy in men. |
| Q36529102 | Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone |
| Q34617878 | Treatment-related osteoporosis in men with prostate cancer |
| Q34435641 | Unresolved issues in osteoporosis in men. |
| Q33586703 | Update in male osteoporosis |
| Q34108855 | Update on the epidemiology of osteoporosis. |
| Q35198511 | Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity |
| Q35748499 | Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome |
| Q96954083 | Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging |
Search more.